Abstract
A series of new chiral 2-(6,8-dichloro-4-methyl-1,1,3-trioxo-3,4-dihydro-1H-1λ6-benzo[1,2,4]thiadiazin-2-yl) carboxylic acids 7a-g containing the chiral amino acid residue were synthesized by adopting the chemical transformations, which have not affected the chirality of the amino acid residue. No significant racemization of the chiral centre was observed during the synthesis of enantiomeric benzothiadiazine 1,1-dioxide derivatives from the corresponding D and L amino acids. Structures of all the newly synthesized compounds were determined by analytical and spectral data.
Keywords: Chiral benzothiadiazine-1, 1-dioxide carboxylic acids, D and L- amino acid derivatives, N-methylation, esterification, hydrolysis
Letters in Organic Chemistry
Title: Synthesis of Chiral 2-(6,8-dichloro-4-methyl-1,1,3-trioxo-3,4-dihydro-1H-1λ6-benzo[1,2,4]thiadiazin-2-yl) Carboxylic Acids Derived from Enantiomeric Amino Acids
Volume: 4 Issue: 6
Author(s): Imtiyaz Ahmed Khazi and Young-Sik Jung
Affiliation:
Keywords: Chiral benzothiadiazine-1, 1-dioxide carboxylic acids, D and L- amino acid derivatives, N-methylation, esterification, hydrolysis
Abstract: A series of new chiral 2-(6,8-dichloro-4-methyl-1,1,3-trioxo-3,4-dihydro-1H-1λ6-benzo[1,2,4]thiadiazin-2-yl) carboxylic acids 7a-g containing the chiral amino acid residue were synthesized by adopting the chemical transformations, which have not affected the chirality of the amino acid residue. No significant racemization of the chiral centre was observed during the synthesis of enantiomeric benzothiadiazine 1,1-dioxide derivatives from the corresponding D and L amino acids. Structures of all the newly synthesized compounds were determined by analytical and spectral data.
Export Options
About this article
Cite this article as:
Imtiyaz Ahmed Khazi and Young-Sik Jung , Synthesis of Chiral 2-(6,8-dichloro-4-methyl-1,1,3-trioxo-3,4-dihydro-1H-1λ6-benzo[1,2,4]thiadiazin-2-yl) Carboxylic Acids Derived from Enantiomeric Amino Acids, Letters in Organic Chemistry 2007; 4 (6) . https://dx.doi.org/10.2174/157017807781467641
DOI https://dx.doi.org/10.2174/157017807781467641 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration
Current Molecular Medicine Vascular Changes of the Retina and Choroid in Systemic Lupus Erythematosus: Pathology and Pathogenesis
Current Neurovascular Research Effects and Perspectives of Chinese Patent Medicines for Tonifying <i>Qi</i> and Promoting Blood Circulation on Patients with Cerebral Infarction
Current Vascular Pharmacology Dietary Lipids and Alzheimer’s Disease
Current Alzheimer Research Nuances in Alzheimer’s Genetic Risk Reveal Differential Predictions of Non-demented Memory Aging Trajectories: Selective Patterns by APOE Genotype and Sex
Current Alzheimer Research Sex-Genetic Interaction in the Risk for Cerebrovascular Disease
Current Medicinal Chemistry Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review
Current Neuropharmacology Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors
Current Topics in Medicinal Chemistry Microglial dependent protective effects of neuroactive steroids
CNS & Neurological Disorders - Drug Targets Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer’s Disease Patients?
CNS & Neurological Disorders - Drug Targets All for Statins and Statins for All; An Update
Current Pharmaceutical Design Association and Causal Relationship of Midlife Obesity and Related Metabolic Disorders with Old Age Cognition
Current Alzheimer Research Good Epidemiologic Practice in Retinitis Pigmentosa: From Phenotyping to Biobanking
Current Genomics Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease
Current Psychopharmacology The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Current Pharmaceutical Design Neuron Protection as a Therapeutic Target in Acute Ischemic Stroke
Current Topics in Medicinal Chemistry The Role of the Brain Renin-Angiotensin System in Neurodegenerative Disorders
Current Alzheimer Research Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
Current Genomics A Model on the Induction of Adverse Vascular Long-Term Effects of NSAIDs
Medicinal Chemistry